Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Kelly Crotty, Ph.D.

Program Director

crottykj@mail.nih.gov

Dr. Kelly Crotty is a Program Director in the Center for Strategic Scientific Initiatives (CSSI) at the National Cancer Institute (NCI). She directs the Innovative Molecular Analysis Technologies (IMAT) program, manages collaborative projects for the Informatics Technology for Cancer Research (ITCR) program, directs the R50 Research Specialist Program, and co-leads NCI's Emerging Technologies Seminar Series.

Dr. Crotty joined the National Cancer Institute in 2019 as an NCI Communications Fellow. She received her Ph.D. in biochemistry from the University of California – San Francisco where she used protein and RNA biochemical methods to investigate the Unfolded Protein Response across yeast species.